• Investing in the Future
    of Kidney Care

    DaVita Venture Group is committed to building partnerships with health care innovators to help improve the lives of patients with kidney disease. Together, we believe we can transform the future of patient care for the better.

About DaVita Venture Group

DaVita Venture Group is part of DaVita Inc., a health care provider focused on transforming care delivery to patients around the globe. We aim to invest in, develop and launch products, solutions and businesses that improve care for patients with kidney disease and related conditions.

Our Priorities

Bringing patient-centered chronic care to scale requires reimagining health care as it exists today. As a result, DaVita Venture Group targets companies and products that support our vision across a few key areas of focus.

Cloud network icon

Digital Health

Digitally enabled products and services that leverage technology, data and connectivity to improve care delivery.

Chemistry beaker icon

Pharmaceuticals and Medical Devices

Products that will improve clinical outcomes and patient experience while reducing costs for the health care system.

Heart rate icon

Care Delivery Models

Advancements that expand access to care and improve clinical outcomes by accelerating the adoption of home treatments and value-based care.

  • Helping Grow the
    Right Opportunities

    As experts in chronic care management, we have a strong vision of what health care could be. Our team reviews each opportunity to find the right ones that will help bring innovative care to patients and, in turn, will reduce the total cost to the health care system.

Our Capabilities

We have built DaVita Venture Group with three complementary capabilities that allow us to tap into outside organizations as well as our very own teammates.

Bar chart


Strategic Investing

We look to invest in early-to-mid stage, growth-oriented businesses that share our mission to transform health care. From improving clinical outcomes through tech-enabled services to expanding access to care with emerging platforms, we want to invest in changing the future of patient care. We operate this fund in collaboration with Healthbox.

>1.7 Million DaVita Patients



We strive to collaborate with other entities to develop, test and bring new technologies to market. We also look to contribute our clinical and operational expertise, resources for product development, insights from data and more.




We are building a pathway for DaVita teammates to develop, pilot and scale innovative ideas with commercial potential. We seek out opportunities that could possibly become new businesses altogether, as well as those that enhance our suite of services within the core kidney care business.

Our Team

Steve Phillips

Vice President, Strategy and Innovation

Mahesh Krishnan, MD, MPH, MBA, FASN

Group Vice President, Research and Development

Daniel Spiegel, MD, MBA

Sr. Director, New Venture Investments

Brian Steers

Director, Partnerships

Daniel Wetmore

Director, Incubation

Jane Rho

Investor, New Venture Investments

Stephen Shin

Manager, Partnerships

Dena Rohde

Executive Assistant